Current Willowbrook LAPPE Students

Jorge Elizondo 
jelizondo@houstonmethodist.org
Hometown: San Antonio Texas
Pharmacy School: University of the Incarnate Word, Feik School of Pharmacy 

Jorge intends to pursue a PGY1 and PGY2 pharmacy residency in one of the following: infectious disease, cardiology, or ambulatory care to positively impact patient outcomes. Prior to pharmacy school, Jorge earned his bachelor's degree in philosophy with a minor in business from The University of Texas at Austin. Exposure to philosophy caused him to understand various healthcare injustices such as the massive healthcare disparities that exist in underserviced areas. Jorge’s passion for pharmacy is fueled by the virtue of attempting to bridge the gap in healthcare one day at a time. Outside of the scope of pharmacy, Jorge spends his time aspiring to become a professional natural bodybuilder. Additionally, he is a personal trainer that loves to educate others about how they can improve their health with modalities such as exercise and nutrition. His electives at Houston Methodist hospital include infectious disease, administration, and critical care.  

Research project: Evaluation of antimicrobial surgical prophylaxis guideline adherence on patients on concurrent therapy 
Hannah Graff
hgraff@houstonmethodist.org
Hometown: Fort Morgan, Colorado 
Pharmacy School: Texas A&M College of Pharmacy

Hannah intends to first pursue a PGY1 residency to work towards a career in ambulatory care or ambulatory care oncology. Prior to pharmacy school, Hannah attended the University of Colorado – Colorado Springs, which is where she made her switch from a nursing degree to pre-pharmacy. Within pharmacy school, she was an active member of Phi Lambda Sigma (PLS), past Texas A&M student director for Texas Pharmacy Association (TPA), Vice President of Patient Care Projects for APhA, and Ambulatory Care Chair for SSHP. She also really enjoyed being the Student Instructor (SI) leader for IPT: Neurology. Hannah’s hobbies outside of pharmacy include spending time with family, baking, and wedding planning. She loves to give back to communities in any way she can by putting on pharmacy service-learning events for mission organizations, volunteering at her church’s nursery, as well as building houses in Juarez, Mexico every year! Her electives at Houston Methodist Willowbrook include infectious disease, critical care, and oncology. 

Research project: To evaluate if hospitalists should consult hematology/oncology team prior to restarting/re-ordering oral anti-neoplastic treatment during admission  
Clifford Jackson III 
cjacksoniii@houstonmethodist.org 
Hometown: Houston, Texas 
Pharmacy School: Texas Southern University College of Pharmacy & Health Sciences 

Clifford intends to pursue both PGY1 and PGY2 residencies in one of the following areas: ambulatory care, ambulatory care oncology, or emergency medicine. Prior to pharmacy school, Clifford graduated from Texas State University with a Bachelor of Science in Biology and a minor in Chemistry, which provided a strong foundation for his transition into pharmacy school. During pharmacy school, Clifford serves as President of the Rho Chi Honor Society and is an active member of Phi Lambda Sigma (PLS), the American Society of Consultant Pharmacists (ASCP), the National Committee Oncology Dispensing Association (NCODA), and the Texas Society of Health-System Pharmacists (TSHP). Outside of pharmacy, Clifford enjoys planning game nights for his family, playing pickleball, watching movies, and spending time outdoors with his wife and dog. Additionally, he is the co-founder and treasurer of the Patricia Lindsey Jackson Foundation, a nonprofit organization dedicated to providing education and resources to populations affected by chronic diseases and cancer, while shaping future generations through the pillars of service, education, and integrity. His electives at Houston Methodist Willowbrook include Emergency Medicine and Oncology. 

Research project: To assess the prevalence and safety profile of rosuvastatin doses above 10 mg in patients on dialysis or with creatinine clearance (CrCl) below 30 mL/min who have undergone PCI or CABG